G LNK is an AI-powered platform that collaborates between health care organization and professionals for drug development.
G LNK has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in March 2025.
G LNK's investors include Y Combinator, Unpopular Ventures.
G LNK is headquartered in New York, United States.
G LNK is an AI-powered platform that collaborates between health care organization and professionals for drug development.
G LNK is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"G LNK — Funding & Investors." VCBacked, March 12, 2025, https://www.vcbacked.co/company/g-lnk. Accessed July 19, 2026.
VCBacked. (2025). G LNK — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/g-lnk
{{cite web |title=G LNK — Funding & Investors |url=https://www.vcbacked.co/company/g-lnk |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated